Find Academic Supervisors

Dr. Rajendra Kurapati is an Assistant Professor at the School of Chemistry , Indian Institute of Science Education and Research Thiruvananthapuram (IISER TVM) . His research focuses on biodegradable 2D materials for biomedical applications, addressing nanomaterial biopersistence issues through enzymatic degradation studies. He leads the Biomaterials Lab and collaborates with institutions across France, Ireland, Portugal, and the UK. Born in Andhra Pradesh, India B.Sc. & M.Sc. in Chemistry (Acharya Nagarjuna University, University of Hyderabad) Ph.D. in Materials Engineering (Indian Institute of Science, 2014) Postdoc: CNRS Strasbourg (2014-2017), CÚRAM Galway (2018-2020) His research explores 2D material-biopolymer hybrids for drug/gene delivery , nanotheranostics , and antimicrobial coatings . Key article trends include: Graphene/MoS2 biodegradation by human enzymes Antibacterial coatings for medical implants Microplastics' environmental impact Lipid nanoparticles for mRNA vaccines ZnO quantum dots for bioimaging Polymer multilayer drug delivery systems Major scientific awards : DBT Ramalingaswami Fellowship (INR 40 lakhs over 5 years) SERB Start-up Grant (32 lakhs over 2 years) SERB Special Grant (45 lakhs over 3 years) DBT Mission Innovation Grant (18 lakhs over 6 months) His academic contributions span 15+ high-impact publications in journals like Advanced Materials , Nanoscale , and Chemical Communications , covering topics from graphene biodegradation to antimicrobial coatings and bioimaging . 10+ alumni students have graduated from his lab, with placements at institutions including University of Strasbourg and Dublin City University.

• Biodegradable Nanomaterials
• Nanomedicine
• Bioengineering
• +5 more

Efstathios (Stathis) Karathanasis is a Professor in the Department of Biomedical Engineering at Case Western Reserve University, holding joint appointments in the Case School of Engineering and the School of Medicine . He serves as the Associate Chair of the Department of Biomedical Engineering and is a member of the Cancer Imaging Program at the Case Comprehensive Cancer Center. His research focuses on integrating nanotechnology with oncology, immunotherapy, and molecular imaging to advance cancer treatment and diagnostics. Education: PhD in Biomedical Engineering, University of Houston (2005) Bachelor of Science in Biomedical Engineering, Aristotle University of Thessaloniki, Greece (1999) Research Interests: Cancer nanotechnology and targeted drug delivery Immunotherapy approaches for solid tumors and pediatric cancers Molecular imaging techniques for cancer diagnosis and treatment monitoring Development of multifunctional nanoparticles for theranostic applications His laboratory, the Cancer Nanotechnology Laboratory , explores how nanotechnology can improve understanding and treatment of cancer, particularly through innovations in nanoparticle design and tumor microenvironment modulation. Grants and Funding: While specific grants are not listed, his research on nanomedicine and immunotherapy is likely supported by NIH or other major biomedical research funding bodies. Labs & Teams: He leads the Cancer Nanotechnology and Immunotherapy Lab , part of the Case Comprehensive Cancer Center, which collaborates with multidisciplinary teams to translate nanotechnology into clinical applications.

• Cancer Nanotechnology
• Immunotherapy
• Pediatric Nanomedicine
• +3 more

Professor Liu Xiaogang is a Distinguished Professor in the Department of Chemistry at the National University of Singapore (NUS). He holds a B. Eng from Beijing Technology and Business University, M.Sc. and Ph.D. degrees in Chemistry from East Carolina University and Northwestern University (USA), respectively, and completed postdoctoral research at MIT. His research focuses on supramolecular coordination chemistry, catalysis, chemical sensors, optogenetics, photon upconversion, and X-ray photonics. Key achievements include pioneering work on metal-organic complexes for optoelectronics and developing advanced X-ray scintillators for medical imaging. Education: B. Eng, Beijing Technology and Business University, China M.Sc. Chemistry, East Carolina University, USA Ph.D. Chemistry, Northwestern University, USA Postdoctoral Associate, Massachusetts Institute of Technology, USA Research Highlights: Professor Liu’s lab has produced groundbreaking advancements in luminescent materials, including directive giant upconversion via supercritical bound states and real-time single-proton counting scintillators. His work bridges chemistry, materials science, and biomedical applications, with notable contributions to photon upconversion, X-ray imaging technologies, and nanotheranostics. Awards: RSC Centenary Prize (2024) President’s Science Award (2016) Advising & Grants: As Principal Investigator of the Liu Lab at NUS, he oversees a dynamic research group focused on cutting-edge nanomaterials and their applications in healthcare and photonics. His grants include support for projects on X-ray luminescence imaging and optogenetic tools. Labs & Teams: The Liu Lab operates within NUS’s Department of Chemistry, collaborating with interdisciplinary teams to advance materials innovation for biomedical and environmental challenges.

• Supramolecular coordination chemistry
• Catalysis
• Chemical sensors
• +8 more

Dr. Ong Yong Sze is a Lecturer at Monash University Malaysia’s School of Pharmacy, specializing in precision oncology and nanomedicine. She holds a PhD in Pharmacology (2019) and a Bachelor of Biomedical Science (2013), both from Universiti Putra Malaysia. Her research focuses on cancer nanomedicine, natural product-based therapeutics, and environmental health risk assessment, with a commitment to developing low-toxicity therapies and addressing environmental pollutants’ health impacts. She has received prestigious awards, including the PeerJ Award for Best Poster (2021) and Oral Presentation Award (2025). Education: PhD in Pharmacology, Universiti Putra Malaysia (2019) Bachelor of Biomedical Science, Universiti Putra Malaysia (2013) Research Interests: Her work bridges nanotechnology, natural pharmacology, and toxicity studies. Key areas include engineering targeted nanoparticle drug delivery systems, exploring plant-derived anticancer compounds, and evaluating environmental pollutants like microplastics. Her interdisciplinary approach aims to enhance therapy precision while ensuring patient safety. Grants & Projects: She leads and collaborates on projects such as Development of a 3D Metastatic Breast Cancer-on-Chip Model (2023–2025) and Engkabang as High-Quality Cosmeceuticals (2023–2026), focusing on drug delivery, gut health, and functional foods. Lab & Teams: Her lab integrates nanomedicine and environmental toxicology, with collaborations spanning Malaysia, Portugal, and Taiwan. She actively organizes workshops on cell culture and drug discovery, furthering academic engagement.

• Cancer Nanomedicine
• Natural Product-Based Therapeutics
• Environmental Toxicology
• +4 more

You-Yeon Won is a Professor of Chemical Engineering at Purdue University's Davidson School of Chemical Engineering, part of the College of Engineering. He leads the Won Laboratory, focusing on polymer science and preclinical proof-of-concept research for polymeric nanomaterials with clinical applications. His work spans three main areas: polymer lung surfactants for respiratory distress syndrome, radioluminescence therapy for cancer radiotherapy, and sequence-controlled PLGA copolymers for drug delivery. Education: B.S. (Summa Cum Laude) from Seoul National University (1992), Ph.D. from the University of Minnesota (2000), followed by postdoctoral work at MIT and Harvard. Joined Purdue in 2003. Research Interests: The lab emphasizes translational research with societal impact, including nanoparticle-based drug delivery systems, polymer-based lung surfactants, and radiation-enhanced therapies. Key advancements include micelleplexes for gene delivery and the development of Polymer Lung Surfactants (PLS) for neonatal care. Awards: Over 20 honors including Most Impactful Faculty Innovator (Purdue, 2020/2023), ACS PRF New Directions Award, and recognition as a KIChE-US Outstanding Young Investigator (2007). His work has led to multiple patents in nanomedicine and drug delivery. Advising & Grants: Mentors graduate students (e.g., Daniel Fesenmeier, Dhushyanth Viswanath) and collaborates with industry and academic partners. Active in entrepreneurship through Purdue's Burton D. Morgan Center. Labs & Teams: The Won Lab includes researchers from undergraduate to visiting faculty levels, with ongoing projects in block copolymer engineering and nanotheranostics. Collaborates with institutions like Harvard, MIT, and Seoul National University.

• Polymer Science
• Nanomedicine
• Biomedical Engineering
• +5 more

Helen Townley is an Associate Professor at the University of Oxford's Engineering Science Department and a Williams Fund Research Fellow. She also serves as a Senior Visiting Research Fellow in Engineering Science and an Associate Editor for Micro and Nano Letters. Her work focuses on nanoparticle-based therapies for cancer, drug delivery systems, and natural product applications in medicine. She holds a BSc (Hons) and PhD in relevant fields. Research Interests: Nanoparticle Cancer Therapy , Enhanced Drug Delivery , and Natural Product Chemotherapy . Her lab explores nanoparticle-mediated drug delivery, chemoembolization, and radiosensitization, with applications in glioblastoma and thalassemia treatment. Collaborations include projects on infertility and antimicrobial biocides. Recent Publications Highlight nano-theranostics , targeted drug delivery, and nanoparticle toxicity studies. Notable awards include the Kajal Mallick Memorial Award (2016) and recognition in BioBeat's '50 Movers and Shakers in BioBusiness 2016'. Advising and Grants: Supervises current and past students (e.g., Jasmine Liu, Ben Gaunt), and collaborates with global teams (e.g., Prof. Robert Kiss). Supported by the Williams Fund and other grants. Lab members include researchers and artists-in-residence.

• Nanoparticle Therapy
• Cancer Research
• Drug Delivery Systems
• +3 more

Anthony Cacace is Professor of Audiology in the Department of Communication Sciences and Disorders at Wayne State University's College of Liberal Arts and Sciences. Formerly tenured faculty at Albany Medical College in Surgery and Neurology, he directed clinical programs including the Audiology Department and Hearing Rehabilitation Center. His expertise spans psychoacoustics, electrophysiology, vestibular assessment, and neuroimaging techniques for tinnitus and auditory processing disorders. Dr. Cacace's educational background includes: B.S. in Speech Pathology and Audiology, State University of New York (1974) M.S. in Audiology, Syracuse University (1975) Ph.D. in Communication Sciences and Disorders/Audiology, Syracuse University (1988) Post Doctoral Fellowship in Neurophysiology, Wadsworth Center (1987) His research focuses on Central Auditory Processing Disorder, tinnitus mechanisms, and noise-induced vestibular dysfunction using TMS, MRI, and electrophysiological methods. Current work investigates blast injury consequences in veterans through VA/DoD-funded projects. Recent publications reveal strong emphasis on tinnitus neuroimaging, auditory processing disorder diagnostics, and vestibular-blast injury relationships. His work integrates diffusion tensor imaging, nanotheranostics, and electrophysiological biomarkers to advance diagnostic and therapeutic frameworks. Scientific recognition includes: ASHA Fellowship (1997) American Academy of Audiology Fellowship (1991) As primary capstone supervisor, Dr. Cacace mentors graduate students while leading multi-institutional research: VA Merit Awards ($1.5M+) on tinnitus and vestibular blast injuries NIH R21 nanotheranostics grant ($141k) Wayne State Omnibus Grants for vestibular/gait equipment He collaborates with Wayne State's Neurosciences Institute, VA Medical Center, and University of Michigan teams studying veteran auditory-vestibular health.

• Psychoacoustics
• Electroacoustics
• Electrophysiology
• +8 more

Panoraia Siafaka is an Assistant Professor in the Department of Life Sciences at European University Cyprus. She holds a PhD in Chemistry from Aristotle University of Thessaloniki (2016), with research focused on polymeric drug delivery systems via electrospinning and phase separation. Her roles include Assistant Professor (2022–present), Scientific Collaborator (2022), and Senior Lecturer (2021–2022). She has contributed to over 50 national and international conferences, including invited lectures on drug delivery systems. Education : PhD (2016): Aristotle University, Chemistry (Polymeric Drug Delivery) MSc (2012): Aristotle University, Chemistry (Polymerization Kinetics) BSc (2010): Aristotle University, Chemistry (Nanocomposite Materials) Research Interests : Her work centers on advanced drug delivery systems using nanotechnology, polymers, and biomaterials for applications in wound healing, ocular drug delivery, neurodegenerative disorders, and cancer therapy. She has pioneered studies on electrospun nanofibers, chitosan-based carriers, and targeted drug delivery platforms. Awards & Recognition : Featured in Stanford’s 2% top global scientists (2021) Outstanding Reviewer, International Journal of Pharmaceutics (2018) Research Excellence Scholarship (2014–2015) Grants & Projects : She has led projects such as Evaluation of Venus Rose Eye Cream Effectiveness (2021–2022) and collaborated on nanotheranostics and localized tumor drug delivery systems. She supervises undergraduate and postgraduate theses in Pharmaceutical Technology and drug formulation design. Labs & Teams : Her research integrates interdisciplinary collaborations, including work at Istanbul Medipol University and EU-funded projects on biocomposites and nanomedicine.

• Drug Delivery Systems
• Polymer Chemistry
• Nanotechnology
• +3 more

Angelo Corti is a Full Professor of Biochemistry at Vita-Salute San Raffaele University , Milan, and heads the Tumor Biology and Vascular Targeting Unit at the San Raffaele Scientific Institute. His career spans roles as a researcher, lecturer, and scientific leader in oncology and molecular medicine. Bachelor's Degree in Biological Sciences (Biochemistry Major), University of Milan (1978, Summa cum laude) Internship at University of Milan (1977-1978) His research focuses on tumor biology, vascular targeting, and cytokine-based therapies, particularly exploring TNF-α, IFN-γ, chromogranin A, and integrin-targeting peptides. Key subfields include angiogenesis inhibition , engineered cytokines , and nanotheranostics . Recent publications highlight integrin-targeted imaging agents, collagen detection, and CD13 inhibition in cancer. Scientific Committees: AIRC Scholarships Scientific Committee, American Association for Cancer Research, European Society for Cancer Immunology and Immunotherapy Grants: Principal investigator for AIRC, CRUK, MURST, and pharmaceutical companies He has co-supervised numerous theses and directed translational research on vascular targeting strategies like NGR-TNF, now in clinical trials. His lab develops engineered peptides and assays for tumor targeting and diagnostics.

• Tumor Biology
• Vascular Targeting
• Biochemistry
• +4 more

Christian Dzuvor is a Post-Doctoral Research Fellow at Harvard University's T.H. Chan School of Public Health and Department of Immunology and Infectious Diseases. Previously, he completed his PhD in Chemical and Biological Engineering at Monash University (2019–2022) and holds a BSc (Hons) in Chemical Engineering from Kwame Nkrumah University of Science and Technology (KNUST), Ghana (2017). His research focuses on integrating protein engineering, nanotechnology, and immunology to develop novel vaccines, antibody therapeutics, and antimicrobial agents against emerging pathogens like coronaviruses and drug-resistant bacteria. Education: PhD in Chemical and Biological Engineering, Monash University (2019–2022) BSc (Hons) in Chemical Engineering, KNUST (2013–2017) Research Interests: Viral immunology, universal vaccine design, protein nanotechnology, antimicrobial peptides, and interdisciplinary approaches to pandemic preparedness. He is particularly inspired by his mentor Prof. Kizzmekia S. Corbett (designer of the Moderna SARS-CoV-2 vaccine) to engineer safe and effective vaccines and antibodies for future pandemics. Awards & Honors: Distinguished Global Talent Awardee (Australian Government, 2020) Monash Graduate Research Scholarship (2019–present) International Postgraduate Research Scholarship (2019–present) Grants & Collaborations: His PhD research was supported by an ARC grant (DP210103595) focusing on peptide-based nanoparticles against superbugs. Current work at Harvard emphasizes viral immunology and universal vaccine development. Labs & Teams: Works in Prof. Kizzmekia S. Corbett's lab at Harvard, focusing on immunological approaches to combat emerging viral threats. Active in networks like VIIN (Victorian Infection and Immunity Network) and Ausbiotech.

• Vaccinology
• Emerging Infectious Diseases
• Antibody Therapeutics
• +6 more

Dr. Priyanka Dey is a Researcher at the University of Exeter, UK, affiliated with the BioSpec group within the School of Physics and Astronomy. She holds a PhD in Chemistry from Queensland University of Technology (QUT), Australia, specializing in nanotechnology and optical spectroscopy. Her work focuses on plasmonic nanostructures for optical sensors, including LSPR, SERS, and deep tissue diagnostics, with applications in cancer detection and water treatment. She has led collaborative projects funded by EPSRC, EU H2020, and others, involving institutions like ICN2 (Spain), LMU Munich (Germany), and QUT. Education: Masters in Material Engineering, IIT Delhi, India PhD in Chemistry (Nanotechnology/Optical Spectroscopy), QUT, Australia Research Interests: Development of nanoplasmonic sensors for POC diagnostics Raman-based deep tissue imaging (SESORS) Hybrid nanoparticles for biomedical and environmental applications Awards: 2018 EU Seal of Excellence Award 2015 Outstanding Doctoral Thesis (QUT) 2013 HDR Student of the Month (QUT) Grants & Projects: EPSRC Programme Grant (RaNT) for Raman nanotheranostics H2020 RAIS project for sepsis diagnostics UNION EU FP7 project for plasmonic nanoassemblies Labs/Teams: Active in the BioSpec group, collaborating with global institutions on nanoplasmonic technologies.

• Plasmonic Sensors
• Nanoplasmonic Diagnostics
• Point-of-Care Diagnostics
• +5 more

Professor Yun Wu is a faculty member in the Department of Biomedical Engineering at the School of Engineering and Applied Sciences, University at Buffalo. She leads the Engineered Theranostics Laboratory, focusing on nanotechnology-enabled solutions for cancer detection and treatment. Her research integrates engineering principles with biomedical applications. PhD in Chemical and Biomolecular Engineering from The Ohio State University (2009) Postdoctoral work at Ohio State's Nanoscale Science and Engineering Center (2009-2013) Assistant/Associate/Full Professor at University at Buffalo (2013-present) Yun Wu's research spans cancer theranostics through: Development of multifunctional nanoparticles for drug/gene delivery Exosome-based biosensor platforms for liquid biopsy Microfluidic methods for nanoparticle synthesis Targeted cancer therapies overcoming drug resistance Biodegradable zwitterionic polymers as PEG alternatives Surface plasmon resonance biosensors for protein/RNA detection Her 15 most recent publications demonstrate expertise in: Exosome isolation and biomarker analysis Lipoplex nanoparticle engineering Multi-drug delivery systems Photoacoustic and fluorescence imaging Pharmacokinetic modeling Clinical translation of nanotherapeutics Current research grants include: $3.1M NCI grant for Exo-PROS lung cancer detection (2022-2027) $2.4M NIBIB project on zwitterionic polymer-drug conjugates (2023-2027) $0.4M NCI grant for exosomal glycoantigen biomarkers (2022-2024) Co-investigator in $0.9M NHLBI fibrosis-on-chip system (2020-2023) Lab members include PhD, MS, and undergraduate researchers. Collaborations exist with Roswell Park Comprehensive Cancer Center and Mayo Clinic clinicians.

• Cancer theranostics
• Biosensors
• Cancer biomarkers
• +2 more

Pablo Taboada Antelo is a University Professor in the Department of Particle Physics at the University of Santiago de Compostela, affiliated with the Materials Institute (iMATUS) and the Colloid and Polymer Physics Group. He obtained his PhD in Physics in 1999 and conducted postdoctoral research at universities in Bilbao, Manchester, and Dublin. With over 240 publications (H-index: 31), he directs extensive research in nanostructured materials for biomedical and energy applications. His work spans theranostics, drug delivery systems, amyloid disease mechanisms, and biosensing. He has supervised 21 PhD theses and serves on editorial boards of Frontiers in Bioengineering and Pharmaceutics. Research emphasizes nanoparticle design, biomaterial interfaces, and computational modeling of biological processes.

• Nanostructured Materials
• Biomedical Applications
• Drug Delivery
• +5 more

Assoc. Professor Moeava Tehei is an academic leader in targeted nanotherapies and medical radiation physics at the University of Wollongong (UOW), School of Physics, within the Faculty of Engineering and Information Sciences. He leads the Targeted Nano-Therapies team at the Centre for Medical Radiation Physics (CMRP) and serves as Head of Postgraduate Studies in Physics (2024–present). He holds a PhD in Physics from Grenoble Alpes University (France, 2002) and has over two decades of expertise in radiation-based cancer therapies, synchrotron applications, and nanoparticle research. Research interests span targeted nanoparticle-enhanced radiotherapy, synchrotron microbeam radiation therapy (MRT), and multimodal cancer treatment strategies. His work integrates biophysics, nanotechnology, and clinical translation, with a focus on glioblastoma and other brain cancers. Key contributions include pioneering the use of high-Z nanoparticles as radiosensitizers and advancing preclinical models for MRT efficacy testing. Tehei has secured over $2 million in competitive grants, including an NHMRC Project Grant as lead CI. He founded the Targeted Nano-Therapies team (2012) and co-organized major conferences like Radiation 2012 and Innovation in Radiation Applications 2017. His editorial roles include membership on the boards of Scientific Reports (Nature) and Journal of Nanotheranostics . Award-winning research includes the French Neutron Society's Thesis Prize and Biophysics Society's Young Researcher Prize. His students have won national awards in biomedical engineering and physics. Current leadership roles include Faculty Education Committee membership and integrity officer duties at UOW. Key facilities used: Australian Synchrotron, preclinical imaging systems (IVIS SpectrumCT), and advanced flow cytometry setups. Research aligns with SDGs 3 (Health) and 9 (Innovation in Industry).

• Medical Physics
• Cancer Biology
• Nanomedicine
• +4 more

Filipa Lourosa Sousa is a Junior Researcher at the University of Aveiro's Department of Chemistry and CICECO - Aveiro Institute of Materials. She holds a PhD in Polyoxometalate Chemistry from the University of Aveiro (2010) and has conducted postdoctoral research in magnetic and optically active microcapsules. Her research focuses on microencapsulation, polyoxometalate-based materials, and their applications in biomedicine and advanced materials. Education: BSc in Chemistry (2000), University of Aveiro MSc in Materials Science and Engineering (2003), University of Aveiro PhD in Chemistry (2010), University of Aveiro under Prof. Dr. Achim Müller Research Interests: Development of smart microcapsules for drug delivery and thermal therapies Metal-oxide clusters and magnetic dry fluids Functional hybrid materials for biomedical applications Publications: Filipa has authored 27 journal articles, 1 book chapter, and 2 theses, with an h-index of 11. Her work spans advanced drug screening in 3D tumor models, pH/NIR-responsive hydrogels, and polyoxometalate composites for cancer therapy. Awards: None explicitly mentioned, but her contributions to nanomedicine and materials science are recognized through her publication record and collaborative projects. Advising & Grants: Supervised 5 MSc/PhD students and participated in European and industry-funded projects like O2CELLS (HORIZON) and PlatILPlus (FCT). Active collaborator with institutions such as New York University and University of Tokyo. Labs/Teams: Principal investigator in CICECO's nanomedicine and materials chemistry groups, contributing to interdisciplinary research in biomaterials and drug delivery.

• Microencapsulation
• Polyoxometalate Chemistry
• Smart Materials
• +5 more